Skip to content

Diasol 100000-75200

by Diasol Inc

Diasol 100000-75200 (ACG1) is a haemodialysis concentrate (FDA Class II; FDA product code KPO, Dialysate Concentrate For Hemodialysis (Liquid Or Powder)) made by Diasol Inc, cleared under FDA 510(k) K851431 on 12 Jun 1985 and listed in FDA GUDID since 13 Feb 2017 (UDI-DI B46710000075200), active as of 23 Oct 2026. 8 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

7 ongoing

This device is named in the recall

Documents

510(k) K851431

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing NumberB46710000075200 UDI-DI Date13 Feb 2017ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK851431 Date12 Jun 1985DecidedStatusActive

Official records

From the FDA record

Device description
Diasol Liquid Acid Concentrate for Bicarbonate Dialysis
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K851431 decided 12 Jun 1985 Active
  • FDA GUDID UDI-DI B46710000075200 listed 13 Feb 2017 Listed

Recalls

8 recalls · 7 ongoing · FDA

  • 6 recalls, same reason

    • Ongoing Z-0991-2026 FDA Class II initiated 5 Nov 2025
    • Ongoing Z-0992-2026 FDA Class II initiated 5 Nov 2025
    • Ongoing Z-0989-2026 FDA Class II initiated 5 Nov 2025
    • Ongoing Z-0990-2026 FDA Class II initiated 5 Nov 2025
    • Ongoing Z-0987-2026 FDA Class II initiated 5 Nov 2025
    • Ongoing Z-0988-2026 FDA Class II initiated 5 Nov 2025

    Safety and efficacy of dialysis acid concentrate cannot be assured

    • Ongoing Z-0207-2025 FDA Class II initiated 27 Jul 2022

    Due to labeling issue. The box label is different that the gallon label in that gallon label shows a lower Calcium concentration than the box label.

    • Terminated Z-2402-2020 FDA Class II initiated 30 Apr 2020

    Incorrect labeling of dialysate concentration for hemodialysis.

Timeline

10 dated events

  1. Cleared FDA 510(k) K851431
  2. Listed FDA GUDID B46710000075200
  3. Recall initiated FDA recalls Z-2402-2020
  4. Recall initiated FDA recalls Z-0207-2025
  5. Recall initiated FDA recalls Z-0991-2026
  6. Recall initiated FDA recalls Z-0992-2026
  7. Recall initiated FDA recalls Z-0989-2026
  8. Recall initiated FDA recalls Z-0990-2026
  9. Recall initiated FDA recalls Z-0987-2026
  10. Recall initiated FDA recalls Z-0988-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Diasol
Generic name
Haemodialysis concentrate
Model / Ref / Catalog
100000-75200, ACG1
Primary DI / UDI-DI
B46710000075200
510(k) Number
FDA product code
KPO
GMDN term
Haemodialysis concentrate
Device class
Class II
Regulation number
876.5820
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)).

Other devices from Diasol Inc

  • Diasol 80000-10200 Open recall

    Class II
  • Diasol 1002225-75200 Open recall

    Class II
  • Diasol 100220-10100 Open recall

    Class II
  • Diasol 1001225-75200 Open recall

    Class II

See all devices from Diasol Inc →

Properties

  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (10, all answered No)